293 related articles for article (PubMed ID: 23886934)
1. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of CYP1-catalyzed regioselective hydroxylation of estradiol by berberine and its oxidative metabolites.
Chang YP; Huang CC; Shen CC; Tsai KC; Ueng YF
Drug Metab Pharmacokinet; 2015 Oct; 30(5):374-83. PubMed ID: 26403084
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition.
Lo SN; Shen CC; Chang CY; Tsai KC; Huang CC; Wu TS; Ueng YF
Drug Metab Dispos; 2015 Jul; 43(7):1100-7. PubMed ID: 25953522
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
Takemura H; Itoh T; Yamamoto K; Sakakibara H; Shimoi K
Bioorg Med Chem; 2010 Sep; 18(17):6310-5. PubMed ID: 20696580
[TBL] [Abstract][Full Text] [Related]
5. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
7. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes.
Yamaori S; Kushihara M; Yamamoto I; Watanabe K
Biochem Pharmacol; 2010 Jun; 79(11):1691-8. PubMed ID: 20117100
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
9. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
[TBL] [Abstract][Full Text] [Related]
10. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.
Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS
Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964
[TBL] [Abstract][Full Text] [Related]
11. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
13. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic analysis of cDNA-expressed human CYP1A1, CYP1A2, and CYP1B1 with 7-ethoxyresorufin as substrate.
Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():85-90. PubMed ID: 16719376
[TBL] [Abstract][Full Text] [Related]
15. Cytochromes P4501 (CYP1): catalytic activities and inducibility by diesel exhaust particle extract and benzo[a]pyrene in intact human lung ex vivo.
Iba MM; Shin M; Caccavale RJ
Toxicology; 2010 Jun; 273(1-3):35-44. PubMed ID: 20435083
[TBL] [Abstract][Full Text] [Related]
16. Nitidine Chloride-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism.
Mao X; Wang J; Wang Q; Yang L; Li Y; Lin H; Peng Y; Zheng J
Drug Metab Dispos; 2019 Aug; 47(8):919-927. PubMed ID: 31147316
[TBL] [Abstract][Full Text] [Related]
17. Palmatine activates AhR and upregulates CYP1A activity in HepG2 cells but not in human hepatocytes.
Vrba J; Havlikova M; Gerhardova D; Ulrichova J
Toxicol In Vitro; 2014 Jun; 28(4):693-9. PubMed ID: 24583342
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.
Mikstacka R; Rimando AM; Dutkiewicz Z; Stefański T; Sobiak S
Bioorg Med Chem; 2012 Sep; 20(17):5117-26. PubMed ID: 22863525
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
20. Berberine Activates Aryl Hydrocarbon Receptor but Suppresses CYP1A1 Induction through miR-21-3p Stimulation in MCF-7 Breast Cancer Cells.
Lo SN; Wang CW; Chen YS; Huang CC; Wu TS; Li LA; Lee IJ; Ueng YF
Molecules; 2017 Oct; 22(11):. PubMed ID: 29143794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
